QQ客服 官方微博 反馈留言

浏览/检索结果: 共17条，第1-10条 帮助 限定条件 发表日期：2015    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Eradication of B cell tumors by minicircle DNA-mediated CD20/CD3 bispecific antibody production 会议论文 New horizons in cancer research, 中国上海 作者:  Xiao-Juan Pang;  Fei Ma;  Pei-Fa Zhang;  Jing Zhang;  Yu-Jian Zhong 收藏  |  浏览/下载：20/0  |  提交时间：2016/01/27 Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma 会议论文 作者:  Shi, Yuankai;  Dong, Mei;  Zhu, Jun;  Zhou, Daobin;  Huang, Huiqiang 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/13 Dysregulation of MYC Driven By BCR-PI3K-AKT Signaling Pathway in Diffuse Large B-Cell Lymphoma 会议论文 作者:  Wang, Wei-Ge;  Jiang, Xiang-Nan;  Liu, Ze-Bing;  Zhou, Xiao-Yan;  Li, Xiao-Qiu 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/13 Palbociclib (PD-0332991), a Potent Selective CDK4/6 Inhibitor, Overcomes Therapy-Resistant and Sensitizes Diffuse Large B-Cell Lymphoma Pre-Clinical Models to Chemo-Reagents 会议论文 作者:  Gu, Juan J.;  Zhang, Qunling;  Mavis, Cory;  Czuczman, Myron S.;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Metformin Induces p53-Dependent Mitochondrial Stress in Therapy-Sensitive and - Resistant Lymphoma Pre-Clinical Model and Primary Patients Sample with B-Cell Non-Hodgkin Lymphoma (NHL) 会议论文 作者:  Gu, Juan J.;  Zhang, Qunling;  Mavis, Cory;  Czuczman, Myron S.;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Dysregulation of MYC Driven By BCR-PI3K-AKT Signaling Pathway in Diffuse Large B-Cell Lymphoma 会议论文 作者:  Wang, Wei-Ge;  Jiang, Xiang-Nan;  Liu, Ze-Bing;  Zhou, Xiao-Yan;  Li, Xiao-Qiu 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Radiation Therapy Alone Not Inferior to Chemoradiation in the Patients With Stage I Nasal Natural Killer/T-Cell Lymphoma 会议论文 作者:  Ma, X.;  Guo, Y.;  Pan, Z.;  Li, X. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Dual Inhibition of PKC Delta By Carfilzomib (CFZ) and Ibrutinib Results in Synergistic Activity in Rituximab-Chemotherapy Sensitive and Resistant Lymphoma Pre-Clinical Models and in Primary Tumor Cells Isolated from B-Cell Lymphoma Patients 会议论文 作者:  Zhang, Qunling;  Gu, Juan J.;  Guo, Ye;  Klos, Jacob;  Mavis, Cory 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Carfilzomib, a second-generation proteasome inhibitor, to enhance the activity of ibrutinib in rituximab-chemotherapy sensitive or resistant B-cell lymphoma cell lines and primary patient samples. 会议论文 作者:  Zhang, Qunling;  Gu, Juan J.;  Mavis, Cory;  Guo, Ye;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Predictive value of F-18 FDG PET/CT quantification parameters for progression-free survival in patients with B-cell lymphoma 会议论文 作者:  He, W.;  Zhai, W.;  Yu, W. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19